View On Demand

Protecting Pre-Term Babies From BPD

About the Event

Each year as many as 15,000 babies in the U.S. develop Bronchopulmonary Dysplasia (BPD), a condition that is the leading cause of death in premature infants. 

AyuVis is a biopharmaceutical company dedicated to helping pre-term babies grow into normal, healthy adults. They have developed a first-in-class small molecule treatment for BPD that has shown great promise in pre-clinical testing and has been granted Orphan Drug Status by the FDA. The company has completed the Pre-IND meeting and is in the process of its Phase 1 filing.

Please join our webinar to hear from AyuVis founder and CEO, Dr. Suchi Acharya, who will talk about the dire need for this treatment and the rapid progress that’s being made in saving the lives of these most vulnerable babies.

View On-Demand Webinar


All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.